CAS: 1070790-89-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CYC065 REF: IN-DA01EOQ8CAS: 1070790-89-4 | 98% | To inquire | Wed 11 Dec 24 |
 | Fadraciclib REF: TM-TQ0053CAS: 1070790-89-4 | 99.75% | 47.00 €~799.00 € | Wed 18 Dec 24 |
 | CYC065 REF: 3D-BC175840CAS: 1070790-89-4 | Min. 95% | To inquire | Wed 22 Jan 25 |
Ref: IN-DA01EOQ8
| 1mg | 51.00 € | ||
| 5mg | 107.00 € | ||
| 10mg | 189.00 € | ||
| 25mg | 220.00 € | ||
| 50mg | 482.00 € | ||
| 100mg | 580.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Fadraciclib
CAS:1070790-89-4
Fadraciclib (CYC065) is an orally available, second-generation ATP-competitive inhibitor of CDK2/CDK9 kinases (IC50s: 5/26 nM).
Formula:
C21H31N7O
Purity:
99.75%
Color and Shape:
Solid
Molecular weight:
397.52
Ref: TM-TQ0053
| 1mg | 47.00 € | ||
| 5mg | 98.00 € | ||
| 10mg | 172.00 € | ||
| 25mg | 293.00 € | ||
| 50mg | 422.00 € | ||
| 100mg | 593.00 € | ||
| 200mg | 799.00 € | ||
| 1mL*10mM (DMSO) | 107.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
CYC065
CAS:1070790-89-4
Inhibitor of CDK2/CDK9 kinases
Formula:
C21H31N7O
Purity:
Min. 95%
Molecular weight:
397.52 g/mol
Ref: 3D-BC175840
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
